<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2021.753711</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Single-Cell Transcriptome Profiles Reveal Fibrocytes as Potential Targets of Cell Therapies for Abdominal Aortic Aneurysm</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Bolun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1468132/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname> <given-names>Xiaomin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1535837/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Guo</surname> <given-names>Wenjun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1196843/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hou</surname> <given-names>Yangfeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1196846/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname> <given-names>Huiyuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ge</surname> <given-names>Weipeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1196863/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fan</surname> <given-names>Tianfei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1196930/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname> <given-names>Zhifa</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Zhiwei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Peiran</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1428615/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gao</surname> <given-names>Ran</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1196848/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhao</surname> <given-names>Hongmei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1194015/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/710891/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>State Key Laboratory of Medical Molecular Biology, Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>First Clinical College, Xi&#x00027;an Jiaotong University</institution>, <addr-line>ShaanXi</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Basic Medical Sciences, School of Medicine, Tsinghua University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Ha Won Kim, Augusta University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Xiaochun Long, Augusta University, United States; Ting Zhou, University of Wisconsin-Madison, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Hongmei Zhao <email>hongmeizhao&#x00040;ibms.pumc.edu.cn</email></corresp>
<corresp id="c002">Ran Gao <email>ggrr1991&#x00040;outlook.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine</p></fn>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn></author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>753711</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Li, Song, Guo, Hou, Hu, Ge, Fan, Han, Li, Yang, Gao, Zhao and Wang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Li, Song, Guo, Hou, Hu, Ge, Fan, Han, Li, Yang, Gao, Zhao and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract><p>Abdominal aortic aneurysm (AAA) is potentially life-threatening in aging population due to the risk of aortic rupture and a lack of optimal treatment. The roles of different vascular and immune cells in AAA formation and pathogenesis remain to be future characterized. Single-cell RNA sequencing was performed on an angiotensin (Ang) II-induced mouse model of AAA. Macrophages, B cells, T cells, fibroblasts, smooth muscle cells and endothelial cells were identified through bioinformatic analyses. The discovery of multiple subtypes of macrophages, such as the re-polarization of <italic>Trem2</italic><sup>&#x0002B;</sup><italic>Acp5</italic><sup>&#x0002B;</sup> osteoclast-like and M2-like macrophages toward the M1 type macrophages, indicates the heterogenous nature of macrophages during AAA development. More interestingly, we defined CD45<sup>&#x0002B;</sup>COL1<sup>&#x0002B;</sup> fibrocytes, which was further validated by flow cytometry and immunostaining in mouse and human AAA tissues. We then reconstituted these fibrocytes into mice with Ang II-induced AAA and found the recruitment of these fibrocytes in mouse AAA. More importantly, the fibrocyte treatment exhibited a protective effect against AAA development, perhaps through modulating extracellular matrix production and thus enhancing aortic stability. Our study reveals the heterogeneity of macrophages and the involvement of a novel cell type, fibrocyte, in AAA. Fibrocyte may represent a potential cell therapy target for AAA.</p></abstract>
<kwd-group>
<kwd>abdominal aortic aneurysm</kwd>
<kwd>single cell sequencing</kwd>
<kwd>fibrocytes</kwd>
<kwd>cell therapy</kwd>
<kwd>cell atlas</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="56"/>
<page-count count="15"/>
<word-count count="8684"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Abdominal aortic aneurysm (AAA) is an aging-related vascular disease. During the progression of AAA, the aneurysm slowly expands and acutely causes vessel rupture without any symptom and warning in advance, resulting in high mortality. For patients with ruptured AAAs, endovascular repair or open repair are the main clinical remedies. However, even undergoing intervention for repair, the in-hospital mortality is still as high as 53.1% (<xref ref-type="bibr" rid="B1">1</xref>). New therapies, such cell or stem cell therapies, have been proposed but have encountered difficulties in their development. Therefore, it is necessary to investigate the mechanism of AAA formation and identify the novel biomarkers or therapies to diagnose and treat AAA patients.</p>
<p>Previous studies revealed that AAA was caused by chronic inflammation and an imbalance between synthesis and degradation of extracellular matrix (ECM) composed of elastin and collagen (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Chronic inflammation is characterized by infiltration of a variety of immune cells. Macrophages have been most widely studied (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>) as main inflammatory cells. Besides macrophages, the roles of B cells (<xref ref-type="bibr" rid="B5">5</xref>), T cells (<xref ref-type="bibr" rid="B6">6</xref>), and mast cells (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>) in AAA formation have also been reported, while the function of other immune cells like natural killer (NK) T cells in AAA formation is still rarely studied.</p>
<p>In addition to inflammation, another essential pathological feature of AAA is the dysregulation of ECM proteins that are mainly synthesized by vascular smooth muscle cells (SMCs) and adventitial fibroblasts. SMC apoptosis has been identified as a hallmark of AAA pathology (<xref ref-type="bibr" rid="B9">9</xref>). Matrix metalloproteinases (MMPs) are mainly produced by SMCs, fibroblasts and infiltrated macrophages. Increased MMPs lead to matrix degradation, loss of aortic wall integrity, AAA expansion and rupture. The balance of ECM synthesis and degradation is critical for the stability of AAA (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Fibroblasts, as the major matrix-producing cell population, can transform into myofibroblasts to produce ECMs (<xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>In addition to the classical vascular and immune cells, recent evidence suggests that circulating fibrocytes are the bone-marrow derived precursors of fibroblasts and can regulate the ECM (<xref ref-type="bibr" rid="B12">12</xref>). Fibrocytes are found in the plaques of atherosclerosis (<xref ref-type="bibr" rid="B13">13</xref>). In ischemic cardiomyopathy, fibrocytes can be recruited and involved in the fibrosis (<xref ref-type="bibr" rid="B14">14</xref>). Given these possible functions of fibrocytes, they may constitute another essential cell population in AAA formation.</p>
<p>To determine the specific cell types and further explore the molecular mechanisms, we performed single-cell RNA sequencing (scRNA-seq) of mouse AAA tissues, in which different cell types and subtypes in AAA can be defined by unique transcriptomes.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Animal Model</title>
<p>To induce AAA, 8-week-old <italic>ApoE</italic><sup>&#x02212;/&#x02212;</sup> male mice (C57BL/6J, Beijing Vital River Laboratory Animal Technology Co., Ltd. Beijing) were anesthetized with 200 mg/kg ketamine and 10 mg/kg xylazine by intraperitoneal injection, and infused with 1,000 ng/kg/min Ang II (A9525-50MG sigma-Aldrich) or saline with alzet osmotic mini-pumps (Alzet model 2004, DURECT Corp., Cupertino, CA) for 28 days. To evaluate the effect of fibrocytes, 8 &#x000D7; 10<sup>6</sup> fibrocytes were injected into mice via tail vein on days 7 and 21 after Ang II-infusion (1.6 &#x000D7; 10<sup>7</sup> in total). GFP-labeled fibrocytes were injected with the same protocol to trace them <italic>in vivo</italic>. All animal experiments were approved by the Research Ethics Committee of Peking Union Medical College.</p>
</sec>
<sec>
<title>Single-Cell RNA-seq and Analysis</title>
<p>A single-cell cDNA library was generated as previously described (<xref ref-type="bibr" rid="B15">15</xref>). For the isolation of individual cells, both control and AAA mice were anesthetized with ketamine (200 mg/kg) and xylazine (10 mg/kg) by intraperitoneal injection. The normal aorta (one whole aorta from one mouse) or aneurysm tissue (one piece of the supra-renal part with aneurysm from one AAA mouse) were dissected and digested for 15 min at 37&#x000B0;C in PBS containing 200 U/ml collagenase I (SCR103, Sigma Aldrich, Germany), 0.05 U/ml elastase (E1250, Sigma Aldrich, Germany), 5 U/ml neutral protease (LS02111, Worthington, USA), and 0.3 U/ml deoxyribonuclease I (M6101, Promega, USA). The tissue digestion was stopped with DMEM containing 10% FBS (10099141, Gibco, USA.) and the mixture was filtered through a 40 &#x003BC;m cell strainer (15-1040, Biologix, China) to obtain single-cell suspensions. Using the method of 7-amino-actinomycin D (7-AAD) positive cells staining, living aortic cells (7-AAD negative cells) were sorted using a Moflo-XDP (Beckman, USA). Cell suspensions (&#x0007E;10,000 single cells) were next loaded on the Chromium Single Cell Controller (10X Genomics) to generate a single cell and gel bead emulsion (GEM). Single-cell sequencing library preparation was performed according to the instructions of Chromium single cell 3&#x00027; library &#x00026; Gel bead kit v2 (10X Genomics). Libraries were sequenced by Illumina Hiseq X Ten in paired-end to reach &#x0007E;50,000 reads per single-cell (Novo Generation Bioinformatics Technology Co., Ltd.).</p>
<p>The 10X Genomics single-cell transcriptome sequencing data were filtered by removing bases with a mass less than 3 at the beginning and end of the reads, using a CellRanger software suite version 3.0.2 pipeline (<xref ref-type="bibr" rid="B16">16</xref>). The filtered reads were aligned to the MM10 mouse reference genome by STAR. For further analysis and statistics, based on the barcode and gene expression matrix, single-cell data were log-normalized and filtered by the R 3.6.0 package Seurat 3.2.3 (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), with the following parameters: unique gene count per cell &#x0003E;500, cell counts per gene &#x0003E;3 (0.1% of the total cell amount), and percentage of mitochondrial genes &#x0003C;0.05. After the control and AAA samples were combined, the UMAP and automated cluster detection algorithms were performed stepwise. The resolution for cluster identification was set as 0.5. DEGs were identified by the Wilcox test with default parameters and <italic>p</italic> &#x0003C;0.05. DEGs from each cluster were sorted by log<sub>e</sub>-fold change relative to the other clusters. Then, the DEGs of which log-fold change was more than 0 were selected and used for GO analysis by ClusterProfiler 3.14.3 (<ext-link ext-link-type="uri" xlink:href="https://guangchuangyu.github.io/software/clusterProfiler/">https://guangchuangyu.github.io/software/clusterProfiler/</ext-link>). The enriched function or pathway were further clustered to predict the most likely function of the specific cluster. Alternatively, to detect the possible polarization or differentiation process among different clusters, Monocle 2.14.0 (<xref ref-type="bibr" rid="B19">19</xref>) was used for the trajectory analysis. The co-expression level of <italic>n</italic> genes was calculated by <inline-formula><mml:math id="M1"><mml:mroot><mml:mrow><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000D7;</mml:mo><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x000D7;</mml:mo><mml:mo>&#x022EF;</mml:mo><mml:mo>&#x000D7;</mml:mo><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mroot></mml:math></inline-formula> (<italic>e</italic><sub><italic>n</italic></sub> means the expression of the <italic>n</italic>th gene) and the accuracy is confirmed by ROC curve. Velocyto.R v0.6 package were then used for calculating RNA velocity of each single cells and further visualization.</p>
</sec>
<sec>
<title>Flow Cytometry</title>
<p>For flow cytometry analyses, single-cell suspensions of mouse aortae were prepared according to the previous protocol (<xref ref-type="bibr" rid="B20">20</xref>) and stained with following antibodies: 7AAD (00-6993-50, eBioscience, USA), Fluorescent isothiocyanate (FITC) anti-mouse-&#x003B1;-SMA (ab8211, Abcam, United Kingdom), PE-anti-mouse-CD34 (551387, BD, USA), FITC-anti-mouse-CD68 (MA1-82739, Invitrogen, USA), PE-anti-mouse-NK1.1 (ab269324, Abcam, United Kingdom), FITC-anti-mouse-CD19 (11-0193-82, eBioscience, USA), PE-anti-mouse-CD21 (12-0211-82, eBioscience, USA), PE-anti-mouse-CD45 (12-0451-82, eBioscience, USA), and Collagen I (ab88147, Abcam, United Kingdom; at room temperature for 30 min) with Alexa Fluor 488 goat anti-mouse antibody (A32723, Invitrogen, at room temperature for 30 min). Flow cytometry results were analyzed by using FlowJo 7.6 software (FlowJo, LLC., Ashland, Oregon). Statistical analysis was further performed by GraphPad Prism 8.0.</p>
</sec>
<sec>
<title>Isolation and Culture of Bone Marrow-Derived Fibrocytes</title>
<p>Bone marrow-derived fibrocytes were obtained by <italic>in vitro</italic> differentiation of spleen cells as previously described (<xref ref-type="bibr" rid="B21">21</xref>). Spleen cells were isolated from 8-week <italic>ApoE</italic><sup>&#x02212;/</sup><sup>&#x02212;</sup> or generic GFP male mice as previously described (<xref ref-type="bibr" rid="B22">22</xref>). Briefly, spleens were separated, minced and digested at 37&#x000B0;C. Spleen cells were isolated using a 70 &#x003BC;m cell strainer (15-1070, Biologix, China) and cultured in 3 ml of RPMI-1640 (31800-500, Solarbio, China) with L-Glutamine, 20% fetal bovine serum (10099-141, Gibco, Australia), penicillin&#x02013;streptomycin (P1400, Solarbio, China). After 3 days, the medium was changed into Fibrolife basal media (LM-0001, Lifeline Cell Technology, USA) with 25 ng/ml of murine macrophage colony-stimulating factor (M-CSF) (315-02, PeproTech, USA) and 50 ng/ml of murine interleukin (IL)-13 (210-13, PeproTech, USA) and cells were cultured in a humidified incubator containing 5% CO<sub>2</sub> at 37&#x000B0;C for 10 days. To detect whether cells were induced differentiation, we observed the morphological changes under microscopy (Nikon, Tokyo, Japan). Following 10 to 14 days, the adherent cells were harvested and used to injected to mice and immunofluorescence staining.</p>
</sec>
<sec>
<title>Human Aortic Tissue</title>
<p>Human aortic tissue extracts were prepared from the abdominal aortic aneurysm patient (Peking Union Medical College Hospital and Beijing Anzhen Hospital) and from the body of the deceased donor with no detectable vascular disease (Peking Union Medical College Volunteer Corpse Donation Reception Station). Age and gender were matched (<xref ref-type="supplementary-material" rid="SM1">Supplementary Tables S1, S2</xref>). The human donor aortic tissues obtained were approved by the institutional review board of institute of basic medical sciences, Chinese academy of medical sciences. The abdominal aortic aneurysm tissue obtained were approved by the institutional review board of Peking Union Medical College Hospital and Beijing Anzhen Hospital.</p>
</sec>
<sec>
<title>Hematoxylin and Eosin (H&#x00026;E) Staining and Elastin Staining</title>
<p>The mouse aortae were embedded in optical cutting temperature (OCT) compound (4583, Sakura, Netherlands) and the frozen sections were used for H&#x00026;E staining, Elastin staining or immunofluorescence staining. H&#x00026;E staining and Elastin staining were performed by using H&#x00026;E staining kit (G1120, Solarbio, China) elastic staining Kit (HT25A, Sigma-aldrich, Germany) according to the manufactures&#x00027; instructions.</p>
</sec>
<sec>
<title>Immunofluorescence Staining</title>
<p>For immunofluorescence staining, the sections for mouse aortae and human aortae or cells seed in 35 mm glass bottom dish were fixed with 4% paraformaldehyde for 10 min and permeabilized with 1% Triton X-100 for 15 min. Then the sections blocked with 1% bovine serum albumin for 30 min at room temperature and incubated with mouse monoclonal collagen I (ab88147, Abcam, United Kingdom, 1:100 dilution) and rabbit polyclonal CD45 (ab10558, Abcam, United Kingdom, 1:100 dilution) antibodies overnight at 4&#x000B0;C. After washing with PBS three times, sections were incubated Alexa Fluor 488-conjugated goat anti-mouse IgG (H&#x0002B;L) secondary antibody (A-11008, Invitrogen, USA, 1:1,000), Alexa Fluor 594 conjugated goat anti-rabbit IgG(H&#x0002B;L) highly cross-adsorbed secondary antibody (A-11037, Invitrogen, USA, 1:1,000 dilution) for 40 min at room temperature. Finally, sections were mounted with ProLong Gold antifade reagent with DAPI (ab104139, Abcam, United Kingdom). Pictures were taken by confocal microscopy (LSM780, Zeiss).</p>
</sec>
<sec>
<title>Quantification and Statistical Analysis</title>
<p>For animal experiments, the exact number of mice used in each experiment is reported in the figure legends. Normality tests were conducted first. Then, comparisons between two groups were made with an unpaired two-tailed <italic>t</italic>-test or non-parametric test. Comparisons among groups with two factors were made with two-way ANOVA, and <italic>p</italic> &#x0003C; 0.05 was considered statistically significant. Data were presented as mean &#x000B1; standard error of the mean (SEM).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Aortic and Aneurysmal Cell Populations Revealed by scRNA-seq</title>
<p>To explore the cell types involved in AAA, apolipoprotein E&#x02013;deficient (<italic>ApoE</italic><sup>&#x02212;/&#x02212;</sup>) male mice were implanted with Ang II osmotic pump for 4 weeks to induce AAA or underwent sham surgery, and the tissues were collected for scRNA-seq (<xref ref-type="fig" rid="F1">Figure 1A</xref>). After alignment (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1A</xref>) and quality control (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S1B,C</xref>), 7,914 and 9,338 cells from control and AAA groups were combined and included in the subsequent analysis. Unsupervised clustering by Seurat R package revealed 15 distinct clusters (<xref ref-type="fig" rid="F1">Figure 1B</xref>). In accordance with the canonical markers, the clusters were fibroblasts (Cluster 0, 2, 3; <italic>Cd34</italic><sup>&#x0002B;</sup><italic>Pdgfra</italic><sup>&#x0002B;</sup>), macrophages [Cluster 1, 4; <italic>Cd68</italic><sup>&#x0002B;</sup><italic>Ptprc</italic><sup>&#x0002B;</sup> (encoding <italic>Cd45</italic>)], SMC [Cluster 5; <italic>Acta2</italic><sup>&#x0002B;</sup> (encoding &#x003B1;-SMA) <italic>Cd34</italic><sup>&#x02212;</sup><italic>Pdgfra</italic><sup>&#x02212;</sup>], endothelial cells (ECs) [Cluster 6; <italic>Pecam1</italic><sup>&#x0002B;</sup> (encoding <italic>Cd31</italic>), T cells (Cluster 7; <italic>Cd3e</italic><sup>&#x0002B;</sup><italic>Cd8a</italic><sup>&#x0002B;</sup>), B cells (Cluster 8; <italic>Cd19</italic><sup>&#x0002B;</sup>), lymphatic endothelial cells (Cluster 12; <italic>Lyve1</italic><sup>&#x0002B;</sup><italic>Pecam1</italic><sup>&#x0002B;</sup>), and proliferating cells (Cluster 9; <italic>Top2a</italic><sup>&#x0002B;</sup><italic>Mki67</italic><sup>&#x0002B;</sup>)] (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Consistent with previous studies, among all cell types, the proportion of immune cells significantly increased in the AAA group, especially macrophages and B cells (<xref ref-type="fig" rid="F1">Figures 1D,E</xref>). By contrast, fibroblasts and SMCs were reduced after 4-week of Ang II-exposure (<xref ref-type="fig" rid="F1">Figures 1D,E</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Aortic and aneurysmal cell populations revealed by scRNA-seq. <bold>(A)</bold> Schematic diagram of the experimental design. <bold>(B)</bold> Uniform manifold approximation and projection (UMAP) representation of the aligned gene expression data from saline-treated (control, <italic>n</italic> = 7,914, in blue) and Ang II-treated (AAA, <italic>n</italic> = 9,338, in red) aortae of apolipoprotein E (<italic>ApoE</italic><sup>&#x02212;/&#x02212;</sup>) mice, showing partition of 15 distinct clusters (left panel) and cell identities (right panel). <bold>(C)</bold> The expression of marker genes exhibited on UMAP plot (gene expression log-normalized by Seurat). <bold>(D)</bold> UMAP representation of cells showing cellular origins. <bold>(E)</bold> Stacked column chart of the proportion of each identified cell type in control and AAA group individually (Control vs. AAA). <bold>(F)</bold> Heatmap of key genes differentially expressed after Ang II infusion (in the left panel) and the associated Gene Ontology (GO) pathway enrichment (in the right panel). Heatmap showed the relative expression level in each cluster. <bold>(G)</bold> Pie chart of the proportion of fibroblast subtypes in control and AAA groups (Control vs. AAA). SMC: smooth muscle cell.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0001.tif"/>
</fig>
<p>To assess the robustness of the dataset and explore the cellular mechanisms of AAA formation, differentially expressed gene (DEG) were determined by comparing each cell type between AAA and control groups and Gene Ontology (GO) analyses were performed. We found that the functions of &#x0201C;positive regulation of cytokine production,&#x0201D; &#x0201C;regulation of inflammatory response,&#x0201D; and &#x0201C;antigen processing and presentation&#x0201D; (<xref ref-type="fig" rid="F1">Figure 1F</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2A</xref>) was upregulated in macrophages in AAA. Moreover, B cells in this dataset were predicted to be activated to plasma cells with the high expression level of <italic>Cr2</italic> (encoding <italic>Cd21</italic>) and <italic>Ighm</italic>, and the upregulated genes of B cells were mainly enriched in the function of &#x0201C;immunoglobulin mediated immune response.&#x0201D; As for T cells, &#x0201C;natural killer cell activation&#x0201D; was upregulated with increased expression of <italic>Klrb1c</italic> and <italic>Il2rb</italic> in AAA pathogenesis. To validate the results from scRNA-seq analyses, the cells were analyzed by flow cytometry, which confirmed the infiltration of macrophages, and the activation of B cells and NK T cells in AAA (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S3A&#x02013;C</xref>).</p>
<p>Fibroblasts were composed of three clusters (Clusters 0, 2 and 3). The highly expressed genes (HEGs) among these clusters and potential functions of these cells were analyzed. The typical fibroblast functions such as &#x0201C;extracellular matrix organization&#x0201D; and &#x0201C;extracellular structure organization&#x0201D; were enriched in all of the three clusters. HEGs of Cluster 0 were mainly enriched in the function of &#x0201C;transmembrane receptor protein serine/threonine kinase signaling pathway&#x0201D; (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2B</xref>). By contrast, the specifically enriched GO functions of Clusters 2 and 3 were &#x0201C;connective tissue development&#x0201D; and &#x0201C;wound healing&#x0201D; (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2C,D</xref>). Further analysis based on the gene expression patterns determined Cluster 0 as the inactivated fibroblasts, with higher expression of <italic>Cd34</italic> but no expression of <italic>Acta2</italic> (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2E</xref>). By contrast, Cluster 3, with higher expression level of <italic>Acta2</italic> and lower expression level of <italic>Cd34</italic> compared with Cluster 0, was regarded as myofibroblasts (<xref ref-type="bibr" rid="B11">11</xref>). Cluster 2 could be the intermediate types between Cluster 0 and 3. In addition, scRNA-seq data showed that the proportion of <italic>Acta2</italic><sup>&#x0002B;</sup> myofibroblasts increased significantly (<xref ref-type="fig" rid="F1">Figure 1G</xref>) in AAA, which was validated by flow cytometry analysis (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3D</xref>).</p>
<p>In terms of vascular cells, SMCs involved in the function of &#x0201C;regulation of apoptotic signaling pathway&#x0201D; were upregulated in AAA, which was consistent with the increased SMC death in AAA (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2E</xref>). Furthermore, ECM-related functions were enriched in SMCs in the AAA group, suggesting that the SMCs underwent phenotypic transformation in AAA (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2E</xref>). In addition, GO analysis of DEGs of ECs suggested that the upregulated functions were related to leukocyte migration and EC proliferation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2F</xref>), which was consistent with the previous reported function of ECs in AAA formation.</p>
</sec>
<sec>
<title>Heterogeneity and Re-polarization of Macrophage Subtypes in AAA</title>
<p>As the largest and most varied population in our scRNA-seq data, we focused on macrophages (Clusters 1 and 4) and re-clustered them by Seurat (<xref ref-type="fig" rid="F1">Figures 1C&#x02013;E</xref>). We observed four main clusters (Clusters 0&#x02013;3) (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Using canonical markers and HEGs to analyze the macrophage subtypes, we identified <italic>Trem2</italic><sup>&#x0002B;</sup><italic>Acp5</italic><sup>&#x0002B;</sup> osteoclast-like macrophages (Cluster 0), <italic>Mrc1</italic><sup>&#x0002B;</sup><italic>Cd163</italic><sup>&#x0002B;</sup> M2-like macrophages (Cluster 1), <italic>Il1b</italic><sup>&#x0002B;</sup><italic>Ccr2</italic><sup>&#x0002B;</sup> M1-like macrophages (Cluster 2), and <italic>Cd34</italic><sup>&#x0002B;</sup><italic>Col1a2</italic><sup>&#x0002B;</sup> bone marrow-derived fibrocyte (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>) (Cluster 3) (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S4A</xref>). To define the specific gene expression features and potential functions, HEG and GO analyses were performed on three subtypes of macrophages (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Osteoclast-like macrophages (Cluster 0) expressing high levels of <italic>Trem2, Tyrobp, Plin2</italic>, and <italic>Lpl</italic> were enriched in the function of &#x0201C;apoptotic cell clearance&#x0201D; and &#x0201C;lipid storage,&#x0201D; suggesting that osteoclast-like macrophages could be involved in lipid deposition and the phagocytosis of apoptotic cells or lipid. In M2-like macrophages (Cluster 1), C-C motif chemokine (CCL) genes (<italic>Ccl8, Ccl6, Ccl24, Ccl9</italic> and <italic>Ccl12</italic>) were highly expressed, and their enriched function was &#x0201C;mononuclear cell migration,&#x0201D; implying that M2-like macrophages might contribute to the recruitment of mononuclear cells by producing chemokines in AAA pathogenesis. Furthermore, the enriched function of &#x0201C;tissue remodeling&#x0201D; related genes were also highly expressed in M2-like macrophages, which is consistent with the previous reported phenotypic characteristics of M2 macrophages (<xref ref-type="bibr" rid="B24">24</xref>). In M1-like macrophages (Cluster 2), HEGs were mainly enriched in the function of &#x0201C;regulation of cytokine biosynthetic process&#x0201D; and &#x0201C;antigen processing and presentation.&#x0201D; Combining with the high expression of <italic>Il1b</italic> and <italic>Ccr2</italic>, these cells have been predicted to be the most important pro-inflammatory cells in AAA pathogenesis.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Heterogeneity and re-polarization of macrophage subtypes in AAA. <bold>(A)</bold> Uniform manifold approximation and projection (UMAP) representation of the aligned gene expression data in macrophages separated from <xref ref-type="fig" rid="F1">Figure 1B</xref>. <bold>(B)</bold> Heatmap of highly expressed genes (HEGs) from three subtypes of macrophages in <bold>(A)</bold>. <bold>(C)</bold> Heatmap of key genes differentially expressed (in the left panel) after Ang II infusion and the associated GO pathway enrichment (in the right panel). Heatmap showed the relative expression level in each cluster of macrophages. <bold>(D)</bold> Pseudo-time plot by trajectory analysis of three clusters of macrophages (Cluster 0: <italic>Trem2</italic><sup>&#x0002B;</sup><italic>Acp5</italic><sup>&#x0002B;</sup> macrophages; Cluster 1: <italic>Mrc1</italic><sup>&#x0002B;</sup><italic>Cbr2</italic><sup>&#x0002B;</sup> M2-like macrophages; Cluster 2: <italic>Il1b</italic><sup>&#x0002B;</sup><italic>Ccr2</italic><sup>&#x0002B;</sup> M1-like macrophages). <bold>(E)</bold> The expression of key genes in pseudo-time plot.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0002.tif"/>
</fig>
<p>To further analyze the changes of macrophage subtypes between control and AAA groups, DEG and GO analyses were performed on each macrophage subtype. In osteoclast-like macrophages, the genes upregulated in AAA were enriched in the function of &#x0201C;NADH dehydrogenase complex assembly,&#x0201D; &#x0201C;ATP metabolic process,&#x0201D; and &#x0201C;glycolytic process&#x0201D; (<xref ref-type="fig" rid="F2">Figure 2C</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S4B</xref>). In M2-like macrophages, the function of &#x0201C;positive regulation of cytokine production&#x0201D; and &#x0201C;tissue remodeling&#x0201D; were upregulated (<xref ref-type="fig" rid="F2">Figure 2C</xref>). On the other hand, upregulated pro-inflammatory factors, such as <italic>Il1b</italic> and <italic>Thbs1</italic>, were enriched in the function of &#x0201C;positive regulation of cytokine production&#x0201D; in M1-like macrophages. In addition, the expression of genes related to &#x0201C;apoptotic cell clearance&#x0201D; were also increased in M1-like macrophages. More interestingly, we found that the mode of ATP metabolism in osteoclast-like macrophages might be shifted to glycolysis (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S4B</xref>), which is typical of M1 macrophages (<xref ref-type="bibr" rid="B25">25</xref>). Moreover, the upregulated functions of M2-like macrophages were similar to the signature functions of M1-like macrophages. These data together suggest a connection between the three subtypes, which was clarified by trajectory analysis with the Monocle2 R package. As shown in <xref ref-type="fig" rid="F2">Figure 2D</xref>, we found the tendency of transition among different macrophages. As shown by the RNA velocity, we found that osteoclast-like macrophages and M2-like macrophages tended to polarize to M1-like (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S5A,B</xref>). Key genes related to the macrophage polarization were significantly changed among these three subtypes of macrophages. For example, <italic>Klf4</italic> (<xref ref-type="bibr" rid="B26">26</xref>) was highly expressed in M2 compared to M1 cells and was reported to play a crucial role in macrophage polarization (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Deficiency of <italic>Klf4</italic> could evoke a partial loss of M2 but gain of M1. Moreover, the expression of <italic>Cd36</italic> declined from M2 to M1 (<xref ref-type="fig" rid="F2">Figure 2E</xref>), which was proven to be essential for fatty acid uptake and metabolism of M2 macrophages (<xref ref-type="bibr" rid="B27">27</xref>). By contrast, the expression of <italic>Pkm</italic> and <italic>Pgam1</italic> related to glycolysis and gluconeogenesis, increased during the M2 to M1 transition (<xref ref-type="fig" rid="F2">Figure 2E</xref>). The high levels of <italic>Pkm</italic> and <italic>Pgam1</italic> in M1 macrophages indicate that M1 macrophages are glycolytic (<xref ref-type="bibr" rid="B25">25</xref>), which was consistent with our GO analysis above (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Taken together, we identified three subtypes of macrophages in aortic and aneurysmal tissues and we thus proposed that the osteoclast-like and M2-like macrophages might polarize toward M1 type in AAA pathogenesis.</p>
</sec>
<sec>
<title>Identification of Fibrocytes That Were Distinct From Macrophages in AAA</title>
<p>While analyzing the subtypes of macrophages, a remarkable population of <italic>Cd34</italic><sup>&#x0002B;</sup><italic>Col1a2</italic><sup>&#x0002B;</sup> bone marrow-derived fibrocytes (Cluster 3) were found in control aorta and AAA tissues, and tended to increase in AAA (<xref ref-type="fig" rid="F2">Figure 2A</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S6A,B</xref>). When performing HEG analysis on fibrocytes compared with the three subtypes of macrophages, we found that the expression pattern of fibrocytes was exceedingly distinct from macrophages (<xref ref-type="fig" rid="F3">Figure 3A</xref>). ECM-related genes were highly expressed in fibrocytes, such as collagen (<italic>Col1a1, Col1a2, Col3a1, Col5a, Col4a1</italic>, etc.), elastin (<italic>Eln</italic>), matrix metalloproteinases (<italic>Mmp2, Mmp3</italic>, etc.), and periostin (<italic>Postn</italic>) (<xref ref-type="fig" rid="F3">Figure 3A</xref>). GO analysis of HEGs suggested fibrocyte functions such as ECM organization, collagen related process and response to growth factor and wounding (<xref ref-type="fig" rid="F3">Figure 3B</xref>), similar to the functions of fibroblasts (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2B&#x02013;D</xref>). Further trajectory analysis of fibrocytes and macrophages revealed that there might be no connection or transition between the fibrocytes and three subtypes of macrophages (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Taken together, we identified fibrocytes in AAA tissues, whose gene expression patterns and functions were different from those of macrophages.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Identification of fibrocytes that were distinct from macrophages in AAA. <bold>(A)</bold> Heatmap of highly expressed genes (HEGs) from three subtypes of macrophages and fibrocytes (Cluster 3), The HEGs of fibrocytes compared with macrophage subtypes were labeled (lower part), and the HEGs of macrophage subtypes (upper part) were the same as <xref ref-type="fig" rid="F2">Figure 2B</xref>. <bold>(B)</bold> Bar plot of Gene Ontology (GO) pathway enrichment of the HEGs in fibrocytes. <bold>(C)</bold> Pseudo-time plot by trajectory analysis of three clusters of macrophages (Cluster 0: <italic>Trem2</italic><sup>&#x0002B;</sup><italic>Acp5</italic><sup>&#x0002B;</sup> macrophages; Cluster 1: <italic>Mrc1</italic><sup>&#x0002B;</sup><italic>Cbr2</italic><sup>&#x0002B;</sup> M2-like macrophages; Cluster 2: <italic>Il1b</italic><sup>&#x0002B;</sup><italic>Ccr2</italic><sup>&#x0002B;</sup> M1-like macrophages; Cluster 3: <italic>Cd34</italic><sup>&#x0002B;</sup><italic>Col1a2</italic><sup>&#x0002B;</sup> fibrocytes).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Identification and Function of Fibrocytes in AAA Pathogenesis</title>
<p>Bone marrow&#x02013;derived fibrocytes are differentiated from circulating CD14<sup>&#x0002B;</sup> peripheral blood mononuclear cells (PBMCs) and co-express markers of hematopoietic stem cells (CD34<sup>&#x0002B;</sup>), monocyte lineage (CD11b<sup>&#x0002B;</sup>), leukocyte (CD45<sup>&#x0002B;</sup>), and stromal cells (collagen I<sup>&#x0002B;</sup>). These characterizations are used to identify fibrocytes (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B28">28</xref>). In our scRNA-seq analysis, marker genes distinguishing fibrocytes from macrophages were retrieved and combined with the canonical markers to identify fibrocytes from other cell types. Among all cell types, the fibrocyte features distinct from macrophages were remarkably similar with fibroblasts, but the fibrocytes also exhibited leukocyte-like features. This suggests that fibroblasts represent a unique cell type (<xref ref-type="fig" rid="F4">Figure 4A</xref>). For screening the markers of fibrocytes, we calculated the co-expression levels (details in Methods) of the fibroblast features (i.e., <italic>Cd34, Col1a2, Meg3, Aebp1, Dcn, Igfbp7</italic>, and <italic>Nbl1</italic>) and the leukocyte-like features (<italic>Cd45</italic>) and assessed the accuracy and specificity of different feature combinations by ROC curve. The result showed that the combination of <italic>Cd45</italic> and <italic>Col1a2</italic> showed a high specificity (&#x0003E;95%) for identifying fibrocytes with a co-expression level of more than 0.25 (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Fibrocytes were newly identified by co-expression of <italic>Ptprc</italic> and <italic>Col1a2</italic>, and distributed among macrophage, fibroblast and smooth muscle cell clusters (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S6C,D</xref>). Furthermore, we adopted and analyzed a previous single cell RNA-seq dataset from human ascending thoracic aortic aneurysm (<xref ref-type="bibr" rid="B29">29</xref>) (ATAA) to validate our current findings in mice. By calculating the co-expression level of <italic>PTPRC</italic> and <italic>COL1A2</italic>, fibrocytes were also detected in the ATAA dataset. Fibrocytes were mainly distributed among macrophage, fibroblast and smooth muscle cell clusters in the embedding space (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S7A,B</xref>), which is consistent with our results. In addition, the proportions of fibrocytes tended to increase in ATAA patients (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S7C</xref>). Next, the transcriptomic changes of fibrocytes in AAA were analyzed. In terms of the classic markers of fibrocytes, the hematopoietic stem cell- and immune cell-like features (i.e., <italic>Cd34, Ptprc, Itgam</italic>) were decreased but the stromal feature (<italic>Col1a2</italic>) was increased (<xref ref-type="fig" rid="F4">Figure 4C</xref>). DEG analysis of our data showed the upregulation of <italic>Ccl8, Gm2564, Aif1</italic>, and <italic>Lgals3</italic> in fibrocytes, which were enriched in the function of &#x0201C;monocyte chemotaxis.&#x0201D; The expression levels of <italic>Timp1, Tyrobp, Mif, Col1a1, and C3</italic> were increased, and they were enriched in the function of &#x0201C;response to wounding&#x0201D; (<xref ref-type="fig" rid="F4">Figures 4D,E</xref>). These data together suggest the response and recruitment of fibrocytes to the AAA lesion. In addition, ECM and collagen-related functions were upregulated in fibrocytes during AAA formation (<xref ref-type="fig" rid="F4">Figure 4E</xref>), which were similar to fibroblast functions (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures S2B&#x02013;D</xref>). Further combining with the ATAA single cell dataset, DEGs of fibrocytes caused by aortic aneurysms were overlapped with those in our dataset and determined. Specifically, <italic>Timp1, Sfrp2</italic>, and <italic>Sfrp4</italic> were upregulated in both human and mouse samples (<xref ref-type="fig" rid="F4">Figure 4F</xref>). These genes are known to be closely related to AAA formation (<xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B32">32</xref>). Further trajectory analysis between fibroblasts and fibrocytes showed fibrocytes were similar with inactivated fibroblasts and might be differentiated toward myofibroblasts (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S5D</xref>), consistent with their role as the fibroblast progenitor. Taken together, we hypothesized that fibrocytes are recruited to AAA tissues and tend to transform toward fibroblasts to influence AAA pathogenesis by mediating ECMs remodeling.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Identification and function of fibrocytes in AAA pathogenesis. <bold>(A)</bold> Dot plot showing the expression of classic fibrocyte markers and the top 5 highly expressed genes compared with macrophages. <bold>(B)</bold> The ROC curve identifying the sensitivity and specificity of the co-expression of distinct marker genes. <bold>(C)</bold> Violin plots of the expression levels of the classic marker genes that identify fibrocytes during Ang II infusion. <bold>(D)</bold> Differentially expressed genes (DEGs) of fibrocytes during Ang II infusion. <bold>(E)</bold> Bar plot of Gene Ontology (GO) pathway enrichment of DEGs in fibrocytes. <bold>(F)</bold> Dot plot showing the expression of 10 shared DEGs in Ang II model and human ATAA.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0004.tif"/>
</fig>
<p>In order to validate the existence and localization of fibrocytes, co-immunofluorescence staining was performed and the results showed that numerous CD45<sup>&#x0002B;</sup>COL1<sup>&#x0002B;</sup> fibrocytes were significantly increased in both mouse (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>) and human (<xref ref-type="fig" rid="F5">Figures 5C,D</xref>) AAA tissues, suggestive of fibrocytes mainly in the adventitia. Co-localization of CD45 and elastin layers showed that CD45<sup>&#x0002B;</sup> cells were mainly localized in the adventitia (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S8</xref>), further indicating the localization of fibrocytes in the adventitia. Flow cytometry data further confirmed the increase of fibrocytes in mouse AAA tissues (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S9</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Validation and localization of fibrocytes in AAA. <bold>(A)</bold> Representative images of H&#x00026;E staining and the immunofluorescence images of normal aorta and AAA tissue from mice stained with COL1 (green) and CD45 (red). <bold>(B)</bold> Quantification of the number of fibrocytes per aortic area (/mm<sup>2</sup>). The quantitative data were shown as mean &#x000B1; SEM, and the difference between the groups was evaluated by Mann-Whitney test. (Saline: <italic>n</italic> = 5; Ang II: <italic>n</italic> = 10). <bold>(C)</bold> Representative images of H&#x00026;E staining and the immunofluorescence images of normal aorta and AAA tissue from human stained with COL1 (green) and CD45 (red). <bold>(D)</bold> Quantification of the number of fibrocytes per aortic area (/mm<sup>2</sup>). The quantitative data were shown as mean &#x000B1; SEM, and the difference between the groups was evaluated by Mann-Whitney test. &#x0002A;<italic>p</italic> &#x0003C; 0.05, and &#x0002A;&#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.001. (non-AAA: <italic>n</italic> = 3; AAA: <italic>n</italic> = 5).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0005.tif"/>
</fig>
</sec>
<sec>
<title>Alleviation of Ang II-Induced AAA Formation by Reconstitution of Fibrocytes</title>
<p>Fibrocytes have been reported to play essential roles in wound healing, atherogenesis, and lung diseases (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), but their role in AAA is not understood. To test the hypothesized roles of fibrocytes in AAA formation, bone marrow-derived fibrocytes were administered into Ang II-treated mice on days 7 and 21 by tail-vein injection (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Bone marrow-derived fibrocytes were produced from spleen monocytes and cultured with IL-13 (50 ng/ml) and M-CSF (25 ng/ml) for 10 days (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S10</xref>). GFP-labeled fibrocytes from GFP-transgenic mice were then injected into Ang II-infused mice (non-GFP) to trace the cells <italic>in vivo</italic>. By co-staining GFP with fibrocyte markers, GFP-labeled fibrocytes were found to be recruited to AAA tissues (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S11</xref>). More importantly, reconstitution of fibrocytes significantly attenuated AAA formation, demonstrated by a decrease in AAA incidence and mortality (<xref ref-type="fig" rid="F6">Figures 6B,C</xref>), reduced lesion diameters (<xref ref-type="fig" rid="F6">Figures 6D&#x02013;F</xref>) and diminished elastin degradation (<xref ref-type="fig" rid="F6">Figures 6G,H</xref>). Taken together, our data suggest that fibrocytes attenuate Ang II-induced AAA formation.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Alleviation of Ang II-induced AAA formation by reconstitution of fibrocytes. <bold>(A)</bold> Schematic diagram of the fibrocytes reconstitution experiment. <bold>(B)</bold> Survival curves of control and Ang II-infused mice with or without fibrocytes reconstitution [Fibrocyte (&#x02013;): <italic>n</italic> = 5 for control mice and <italic>n</italic> = 25 for Ang II-infusion mice; Fibrocyte (&#x0002B;): <italic>n</italic> = 5 for control mice and <italic>n</italic> = 15 for Ang II-infusion mice]. <bold>(C)</bold> The incidence rate of AAA in control and Ang II-infused mice with or without fibrocytes reconstitution. Fisher exact method was used to test for statistical significance. <bold>(D)</bold> Representative images of whole aortae. <bold>(E)</bold> Quantification of AAA diameter (mm). <bold>(F)</bold> Representative images of H&#x00026;E staining of abdominal aortae. Scale bar = 250 &#x003BC;m. <bold>(G)</bold> Representative images of elastin staining in four groups of mice. Scale bar = 25&#x003BC;m. <bold>(H)</bold> Quantification of the elastin score. The quantitative data were shown as mean &#x000B1; SEM, and the difference between multiple groups was evaluated by two-way ANOVA. &#x0002A;<italic>p</italic> &#x0003C; 0.05, &#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.01, &#x0002A;&#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.001, and &#x0002A;&#x0002A;&#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.0001. [Fibrocyte (&#x02013;): <italic>n</italic> = 5 for control mice and <italic>n</italic> = 14 for Ang II-infusion mice; Fibrocyte (&#x0002B;): <italic>n</italic> = 5 for control mice and <italic>n</italic> = 13 for Ang II-infusion mice].</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcvm-08-753711-g0006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>We performed scRNA-seq analysis of aortic tissues from Ang II-induced AAA mouse model and found infiltration and activation of pro-inflammatory cells such as macrophages, B cells and NK T cells in the AAA tissue. Additionally, myofibroblast activation, SMC apoptosis, and EC dysfunction were also indicated by the results of scRNA-seq. We focused on the heterogeneity of macrophage subtypes, and discovered the repolarization of M2-like and <italic>Trem2</italic><sup>&#x0002B;</sup> osteoclast-like macrophages toward M1-like macrophages, highlighting a critical role of this process in AAA pathogenesis. More importantly, we identified fibrocytes from scRNA-seq analysis and confirmed the recruitment of fibrocytes and their protective effect in AAA formation. Thus, our study has identified specific cell populations critical to AAA and provided evidence supporting these cells as targets for intervention.</p>
<p>Despite the rapidly growing number of single-cell sequencing studies, only a few single-cell datasets of AAA have been published, including data from ATAA patients (<xref ref-type="bibr" rid="B29">29</xref>), the elastase model (<xref ref-type="bibr" rid="B35">35</xref>) and the CaCl<sub>2</sub> model (<xref ref-type="bibr" rid="B36">36</xref>). Hadi et al. conducted scRNA-seq on Ang II-induced AAA tissues and showed the expression of Nertin-1 in different cell types without in-depth analysis on the heterogeneity of cell populations. We performed scRNA-seq in Ang II-induced AAA tissues and obtained consistent findings with previously reported results. For example, B cells have been reported to play a crucial role by producing abundant inflammatory factors in AAA (<xref ref-type="bibr" rid="B37">37</xref>). Depletion of B cells using anti-CD20 could suppress the formation of AAA and evoke the infiltration of immunosuppressive cells (<xref ref-type="bibr" rid="B38">38</xref>). Consistently, we found the activation and increase of B cells, which was confirmed by flow cytometry in AAA. Similarly, the activation of NK T cells has been demonstrated to aggravate AAA formation (<xref ref-type="bibr" rid="B39">39</xref>), which is also consistent with our scRNA-seq and flow cytometry results. Apoptosis of SMCs has become the hallmark of AAA, which is also confirmed in our scRNA-seq data in terms of cell proportions and function analysis. Moreover, both previous studies and our scRNA-seq results showed the vital function of ECs in the recruitment of inflammatory cells during AAA formation. The consistent results from our and previous studies support the important roles of these cell types in AAA.</p>
<p>Our scRNA-seq analysis revealed the heterogeneities of three macrophage subtypes and found the increase of <italic>Trem2</italic><sup>&#x0002B;</sup> osteoclast-like macrophages in AAA tissues. These data were consistent to the previous reports that osteoclast-like macrophages were increased in AAA lesions, and the inhibition of osteoclastogenic differentiation diminished AAA formation (<xref ref-type="bibr" rid="B40">40</xref>&#x02013;<xref ref-type="bibr" rid="B42">42</xref>). In addition, based on the gene expression patterns and trajectory analysis, we proposed the re-polarization of osteoclast-like macrophages and M2-like macrophages toward the M1 type. However, it remains unclear when and how re-polarization takes place in AAA formation, which deserves to be further investigated. Besides promoting inflammation (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2A</xref>), infiltrated macrophages can also influence ECM degradation by secreting proteases, such as cathepsins and MMPs (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). It has been reported that cathepsin S was highly expressed in AAA lesions, and deficiency of cathepsin S attenuated AAA formation by preventing SMC apoptosis and proliferation of inflammatory cells. Consistently, our scRNA-seq data showed an upregulated expression of cathepsins in different macrophages. Specifically, cathepsins S and B were most highly expressed in osteoclast-like macrophages and the expression levels were increased in AAA (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S6A</xref>). Similarly, the expression of a series of cathepsins was upregulated in M2-like macrophages, including <italic>Ctsa, Ctsb, Ctsc, Ctsd</italic> (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S12</xref>). In addition, previous studies have reported that MMP9 and MMP12 produced by macrophages contribute to AAA (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Our data showed that <italic>Mmp9</italic> was highly expressed in M2-like macrophages, and <italic>Mmp12</italic> and <italic>Mmp14</italic> were highly expressed in osteoclast-like macrophages correspondingly (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S6A</xref>). These data together suggest the vital roles of different types of macrophages in AAA formation by differentially regulating inflammation and ECMs remodeling.</p>
<p>Fibrocytes are bone marrow-derived cells maturing in spleen. Fibrocytes are recruited to injured sites and differentiated toward fibroblasts (<xref ref-type="bibr" rid="B23">23</xref>). Previous studies have proposed their roles in wound healing, atherosclerogensis, and lung diseases (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Reconstitution of fibrocytes could accelerate wound healing by upregulating collagen-related genes (<xref ref-type="bibr" rid="B23">23</xref>). Similarly, reconstitution of <italic>Postn</italic><sup>&#x02212;/&#x02212;</sup> fibrocytes diminished bleomycin-induced lung fibrosis (<xref ref-type="bibr" rid="B48">48</xref>). In vascular pathology, fibrocytes were found to be involved in the atherosclerotic plaque formation (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B47">47</xref>). In our study, the reconstitution of fibrocytes reduced the incidence and mortality of Ang II-induced AAA, and attenuated elastin degradation and AAA formation. In our study, we found the activation of fibroblast toward myofibroblast with high <italic>Acta2</italic> expression in AAA (<xref ref-type="fig" rid="F1">Figure 1G</xref>). Importantly, single cell trajectory analyses revealed fibrocytes, as another source, tended to be differentiated toward fibroblasts and then myofibroblasts (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S5D</xref>). The results suggested that the increased myofibroblasts in the AAA group may result from the activation of adventitial fibroblast as well as the recruited and increased fibrocytes. In previous studies, the activation and differentiation of fibroblast toward myofibroblast is a well-established phenomenon during which fibroblasts mature and acquire the contractile feature. This phenotypic transition contributes to vascular pathology by producing inflammatory factors, such as IL-6 and monocyte chemoattractant protein-1 (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). In terms of the source of myofibroblasts, they have been reported to be differentiated from not only fibroblasts, but also from SMCs and fibrocytes (<xref ref-type="bibr" rid="B51">51</xref>), which are consistent with our observations. For the underlying mechanism of transition process, previous studies have revealed the roles of TGF&#x003B2;, hypoxia, angiotension II, endothelin-1, IL-6, hyperhomocysteinemia (HHcy), cylindromatosis (CYLD), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (Nox4), and Fizzl (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B52">52</xref>&#x02013;<xref ref-type="bibr" rid="B55">55</xref>). The enhanced expression of ECM-related genes (i.e., <italic>Col1a1</italic> and <italic>Timp1</italic>) and WNT antagonists (i.e. <italic>Sfrp2</italic> and <italic>Sfrp4</italic>) in fibrocytes (<xref ref-type="fig" rid="F4">Figure 4F</xref>) suggests a protective effect in AAA formation. Additionally, these genes are involved in the TGF&#x003B2; pathway (<xref ref-type="bibr" rid="B56">56</xref>), indicating the transition of fibrocytes to myofibroblasts. The specific mechanisms by which fibrocytes modulate AAA formation need to be further characterized in the future.</p>
<p>In conclusion, this study identified important roles of macrophage subtypes and fibrocytes in AAA by scRNA-seq. Reconstitution experiment with cell tracing confirmed that fibrocytes were recruited and attenuated AAA formation. As clinical treatment for AAA lacks breakthrough, our data provide the theoretical underpinning for fibrocytes as a new approach for cell therapy for AAA treatment or post-operative protection, where fibrocytes can maintain aortic homeostasis and reduce the mortality due to AAA. Additionally, human fibrocytes can be easily derived from PBMCs for autologous cell therapy, providing a new and feasible strategy for future treatment of AAA.</p>
</sec>
<sec id="s5">
<title>Limitation</title>
<p>This study has some limitations. First, we have one AAA mouse versus one saline control for scRNA-seq. Multiple biological replicates in scRNA-seq will more conductive to exploring the heterogeneities of cell types in AAA. However, we did validation experiments to confirm cell heterogeneity in our scRNA-seq data, which were consistent with other scRNA-seq studies (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). The changes among the different cell types in AAA were confirmed by flow cytometry (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). The involvement of fibrocytes in AAA pathogenesis were confirmed by reconstitution experiments in mice (<xref ref-type="fig" rid="F6">Figure 6</xref>). Nevertheless, the results suggested that the cell types analyzed by scRNA-seq data were critical in progression of AAA. Second, the cell types captured and their proportions might be affected by the different enzyme digestion strategies used for obtaining single-cell suspensions, as shown in the previous scRNA-seq studies of vessel tissues (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). In our study, based on our preliminary experiments, we optimized the enzymatic strategy [PBS containing 200 U/ml collagenase I (Sigma Aldrich), 0.05 U/ml elastase (Sigma Aldrich), 5 U/ml neutral protease (Worthington), and 0.3 U/ml deoxyribonuclease I (Promega)]. Our results showed that the cell types and the proportions were similar with the single cell dataset of the CaCl<sub>2</sub> model (<xref ref-type="bibr" rid="B36">36</xref>). In addition, the cleanliness of dissected adventitia can also affect the cell types and its proportions. In this study, we kept more adventitial tissue to acquire complete cell atlas of the aorta, which might have resulted in more fibroblasts in this dataset. Taken together, these factors may have caused the relatively low numbers of vascular smooth muscle cells in the control saline group. Therefore, the method of obtaining single-cell suspensions should be continually optimized in future studies. Finally, we only performed scRNA-seq study in Ang II-induced AAA mouse model. Different animal AAA models show multiple differences in anatomic positions, histological features, and pathological mechanisms. None of the experimental rodent models developed to date is exactly identical to human AAAs. Therefore, our findings need to be confirmed in AAAs from different animal models and perhaps human tissues in the future.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found at: <ext-link ext-link-type="uri" xlink:href="https://ngdc.cncb.ac.cn/gsa/PRJCA006049">https://ngdc.cncb.ac.cn/gsa/PRJCA006049</ext-link>.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Institutional Review Board of Peking Union Medical College Hospital and Beijing Anzhen Hospital. The patients/participants provided their written informed consent to participate in this study. The animal study was reviewed and approved by the Research Ethics Committee of Peking Union Medical College.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>BL, XS, RG, and JW designed the study. XS, RG, HZ, YH, WGu, WGe, HH, and TF performed the experiments. BL, HZ, XS, ZH, and ZL analyzed the data. BL, PY, HZ, and JW wrote the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study was financially supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-1-I2M-016) (to RG); the National Natural Science Foundation of China Grants 82100514 (to RG); the National Key Research and Development Program of China grants 2019YFA0801804 (to JW); Thousand Young Talents Program of China (to JW).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec> </body>
<back><sec sec-type="supplementary-material" id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2021.753711/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2021.753711/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karthikesalingam</surname> <given-names>A</given-names></name> <name><surname>Holt</surname> <given-names>PJ</given-names></name> <name><surname>Vidal-Diez</surname> <given-names>A</given-names></name> <name><surname>Ozdemir</surname> <given-names>BA</given-names></name> <name><surname>Poloniecki</surname> <given-names>JD</given-names></name> <name><surname>Hinchliffe</surname> <given-names>RJ</given-names></name> <etal/></person-group>. <article-title>Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA</article-title>. <source>Lancet.</source> (<year>2014</year>) <volume>383</volume>:<fpage>963</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60109-4</pub-id><pub-id pub-id-type="pmid">24629298</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname> <given-names>RA</given-names></name> <name><surname>Taylor</surname> <given-names>WR</given-names></name></person-group>. <article-title>Cellular mechanisms of aortic aneurysm formation</article-title>. <source>Circ Res.</source> (<year>2019</year>) <volume>124</volume>:<fpage>607</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.313187</pub-id><pub-id pub-id-type="pmid">30763207</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname> <given-names>MA</given-names></name> <name><surname>Ruhlman</surname> <given-names>MK</given-names></name> <name><surname>Baxter</surname> <given-names>BT</given-names></name></person-group>. <article-title>Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2015</year>) <volume>35</volume>:<fpage>1746</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.115.305269</pub-id><pub-id pub-id-type="pmid">26044582</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raffort</surname> <given-names>J</given-names></name> <name><surname>Lareyre</surname> <given-names>F</given-names></name> <name><surname>Clement</surname> <given-names>M</given-names></name> <name><surname>Hassen-Khodja</surname> <given-names>R</given-names></name> <name><surname>Chinetti</surname> <given-names>G</given-names></name> <name><surname>Mallat</surname> <given-names>Z</given-names></name></person-group>. <article-title>Monocytes and macrophages in abdominal aortic aneurysm</article-title>. <source>Nat Rev Cardiol.</source> (<year>2017</year>) <volume>14</volume>:<fpage>457</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2017.52</pub-id><pub-id pub-id-type="pmid">33455994</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furusho</surname> <given-names>A</given-names></name> <name><surname>Aoki</surname> <given-names>H</given-names></name> <name><surname>Ohno-Urabe</surname> <given-names>S</given-names></name> <name><surname>Nishihara</surname> <given-names>M</given-names></name> <name><surname>Hirakata</surname> <given-names>S</given-names></name> <name><surname>Nishida</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Involvement of B cells, immunoglobulins, and syk in the pathogenesis of abdominal aortic aneurysm</article-title>. <source>J Am Heart Assoc.</source> (<year>2018</year>) <volume>7</volume>:<fpage>e007750</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.117.007750</pub-id><pub-id pub-id-type="pmid">29545260</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galle</surname> <given-names>C</given-names></name> <name><surname>Schandene</surname> <given-names>L</given-names></name> <name><surname>Stordeur</surname> <given-names>P</given-names></name> <name><surname>Peignois</surname> <given-names>Y</given-names></name> <name><surname>Ferreira</surname> <given-names>J</given-names></name> <name><surname>Wautrecht</surname> <given-names>JC</given-names></name> <etal/></person-group>. <article-title>Predominance of type 1 CD4&#x0002B; T cells in human abdominal aortic aneurysm</article-title>. <source>Clin Exp Immunol.</source> (<year>2005</year>) <volume>142</volume>:<fpage>519</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02938.x</pub-id><pub-id pub-id-type="pmid">16297165</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuruda</surname> <given-names>T</given-names></name> <name><surname>Kato</surname> <given-names>J</given-names></name> <name><surname>Hatakeyama</surname> <given-names>K</given-names></name> <name><surname>Kojima</surname> <given-names>K</given-names></name> <name><surname>Yano</surname> <given-names>M</given-names></name> <name><surname>Yano</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm</article-title>. <source>Circ Res.</source> (<year>2008</year>) <volume>102</volume>:<fpage>1368</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.173682</pub-id><pub-id pub-id-type="pmid">18451339</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayranpaa</surname> <given-names>MI</given-names></name> <name><surname>Trosien</surname> <given-names>JA</given-names></name> <name><surname>Fontaine</surname> <given-names>V</given-names></name> <name><surname>Folkesson</surname> <given-names>M</given-names></name> <name><surname>Kazi</surname> <given-names>M</given-names></name> <name><surname>Eriksson</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms</article-title>. <source>J Vasc Surg.</source> (<year>2009</year>) <volume>50</volume>:<fpage>388</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvs.2009.03.055</pub-id><pub-id pub-id-type="pmid">19515525</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Candales</surname> <given-names>A</given-names></name> <name><surname>Holmes</surname> <given-names>DR</given-names></name> <name><surname>Liao</surname> <given-names>S</given-names></name> <name><surname>Scott</surname> <given-names>MJ</given-names></name> <name><surname>Wickline</surname> <given-names>SA</given-names></name> <name><surname>Thompson</surname> <given-names>RW</given-names></name></person-group>. <article-title>Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms</article-title>. <source>Am J Pathol.</source> (<year>1997</year>) <volume>150</volume>:<fpage>993</fpage>&#x02013;<lpage>1007</lpage>.<pub-id pub-id-type="pmid">9060837</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isselbacher</surname> <given-names>EM</given-names></name></person-group>. <article-title>Thoracic and abdominal aortic aneurysms</article-title>. <source>Circulation.</source> (<year>2005</year>) <volume>111</volume>:<fpage>816</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000154569.08857.7A</pub-id><pub-id pub-id-type="pmid">15710776</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname> <given-names>B</given-names></name> <name><surname>Phan</surname> <given-names>SH</given-names></name> <name><surname>Thannickal</surname> <given-names>VJ</given-names></name> <name><surname>Prunotto</surname> <given-names>M</given-names></name> <name><surname>Desmouliere</surname> <given-names>A</given-names></name> <name><surname>Varga</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Recent developments in myofibroblast biology: paradigms for connective tissue remodeling</article-title>. <source>Am J Pathol.</source> (<year>2012</year>) <volume>180</volume>:<fpage>1340</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.02.004</pub-id><pub-id pub-id-type="pmid">22387320</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keeley</surname> <given-names>EC</given-names></name> <name><surname>Mehrad</surname> <given-names>B</given-names></name> <name><surname>Strieter</surname> <given-names>RM</given-names></name></person-group>. <article-title>Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis</article-title>. <source>Int J Biochem Cell Biol.</source> (<year>2010</year>) <volume>42</volume>:<fpage>535</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2009.10.014</pub-id><pub-id pub-id-type="pmid">19850147</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zulli</surname> <given-names>A</given-names></name> <name><surname>Buxton</surname> <given-names>BF</given-names></name> <name><surname>Black</surname> <given-names>MJ</given-names></name> <name><surname>Hare</surname> <given-names>DL</given-names></name></person-group>. <article-title>CD34 Class III positive cells are present in atherosclerotic plaques of the rabbit model of atherosclerosis</article-title>. <source>Histochem Cell Biol.</source> (<year>2005</year>) <volume>124</volume>:<fpage>517</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-005-0072-2</pub-id><pub-id pub-id-type="pmid">16177890</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haudek</surname> <given-names>SB</given-names></name> <name><surname>Xia</surname> <given-names>Y</given-names></name> <name><surname>Huebener</surname> <given-names>P</given-names></name> <name><surname>Lee</surname> <given-names>JM</given-names></name> <name><surname>Carlson</surname> <given-names>S</given-names></name> <name><surname>Crawford</surname> <given-names>JR</given-names></name> <etal/></person-group>. <article-title>Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2006</year>) <volume>103</volume>:<fpage>18284</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0608799103</pub-id><pub-id pub-id-type="pmid">17114286</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>T</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Deng</surname> <given-names>N</given-names></name> <name><surname>Huang</surname> <given-names>G</given-names></name> <name><surname>Taghavifar</surname> <given-names>F</given-names></name> <name><surname>Geng</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis</article-title>. <source>Cell Rep.</source> (<year>2018</year>) <volume>22</volume>:<fpage>3625</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.010</pub-id><pub-id pub-id-type="pmid">29590628</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>GX</given-names></name> <name><surname>Terry</surname> <given-names>JM</given-names></name> <name><surname>Belgrader</surname> <given-names>P</given-names></name> <name><surname>Ryvkin</surname> <given-names>P</given-names></name> <name><surname>Bent</surname> <given-names>ZW</given-names></name> <name><surname>Wilson</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Massively parallel digital transcriptional profiling of single cells</article-title>. <source>Nat Commun.</source> (<year>2017</year>) <volume>8</volume>:<fpage>14049</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms14049</pub-id><pub-id pub-id-type="pmid">28091601</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satija</surname> <given-names>R</given-names></name> <name><surname>Farrell</surname> <given-names>JA</given-names></name> <name><surname>Gennert</surname> <given-names>D</given-names></name> <name><surname>Schier</surname> <given-names>AF</given-names></name> <name><surname>Regev</surname> <given-names>A</given-names></name></person-group>. <article-title>Spatial reconstruction of single-cell gene expression data</article-title>. <source>Nat Biotechnol.</source> (<year>2015</year>) <volume>33</volume>:<fpage>495</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id><pub-id pub-id-type="pmid">25867923</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname> <given-names>A</given-names></name> <name><surname>Hoffman</surname> <given-names>P</given-names></name> <name><surname>Smibert</surname> <given-names>P</given-names></name> <name><surname>Papalexi</surname> <given-names>E</given-names></name> <name><surname>Satija</surname> <given-names>R</given-names></name></person-group>. <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>. <source>Nat Biotechnol.</source> (<year>2018</year>) <volume>36</volume>:<fpage>411</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname> <given-names>C</given-names></name> <name><surname>Cacchiarelli</surname> <given-names>D</given-names></name> <name><surname>Grimsby</surname> <given-names>J</given-names></name> <name><surname>Pokharel</surname> <given-names>P</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Morse</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells</article-title>. <source>Nat Biotechnol.</source> (<year>2014</year>) <volume>32</volume>:<fpage>381</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id><pub-id pub-id-type="pmid">24658644</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>K</given-names></name> <name><surname>Shim</surname> <given-names>D</given-names></name> <name><surname>Lee</surname> <given-names>JS</given-names></name> <name><surname>Zaitsev</surname> <given-names>K</given-names></name> <name><surname>Williams</surname> <given-names>JW</given-names></name> <name><surname>Kim</surname> <given-names>KW</given-names></name> <etal/></person-group>. <article-title>Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models</article-title>. <source>Circ Res.</source> (<year>2018</year>) <volume>123</volume>:<fpage>1127</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.312804</pub-id><pub-id pub-id-type="pmid">30571470</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname> <given-names>T</given-names></name> <name><surname>Osawa</surname> <given-names>Y</given-names></name> <name><surname>Izumi</surname> <given-names>T</given-names></name> <name><surname>Nagao</surname> <given-names>S</given-names></name> <name><surname>Takano</surname> <given-names>K</given-names></name> <name><surname>Okada</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis</article-title>. <source>Leukemia.</source> (<year>2017</year>) <volume>31</volume>:<fpage>2709</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/leu.2017.112</pub-id><pub-id pub-id-type="pmid">30232464</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname> <given-names>JR</given-names></name> <name><surname>Pilling</surname> <given-names>D</given-names></name> <name><surname>Gomer</surname> <given-names>RH</given-names></name></person-group>. <article-title>Improved serum-free culture conditions for spleen-derived murine fibrocytes</article-title>. <source>J Immunol Methods.</source> (<year>2010</year>) <volume>363</volume>:<fpage>9</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2010.09.025</pub-id><pub-id pub-id-type="pmid">20888336</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname> <given-names>HK</given-names></name> <name><surname>Chen</surname> <given-names>B</given-names></name> <name><surname>Murphy</surname> <given-names>GF</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <name><surname>Orgill</surname> <given-names>DP</given-names></name> <name><surname>Guo</surname> <given-names>L</given-names></name></person-group>. <article-title>Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis</article-title>. <source>Ann Surg.</source> (<year>2011</year>) <volume>254</volume>:<fpage>1066</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1097/SLA.0b013e3182251559</pub-id><pub-id pub-id-type="pmid">21832942</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>DG</given-names></name> <name><surname>Huang</surname> <given-names>L</given-names></name> <name><surname>VanderVen</surname> <given-names>BC</given-names></name></person-group>. <article-title>Immunometabolism at the interface between macrophages and pathogens</article-title>. <source>Nat Rev Immunol.</source> (<year>2019</year>) <volume>19</volume>:<fpage>291</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0124-9</pub-id><pub-id pub-id-type="pmid">30679807</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Neill</surname> <given-names>LA</given-names></name> <name><surname>Pearce</surname> <given-names>EJ</given-names></name></person-group>. <article-title>Immunometabolism governs dendritic cell and macrophage function</article-title>. <source>J Exp Med.</source> (<year>2016</year>) <volume>213</volume>:<fpage>15</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151570</pub-id><pub-id pub-id-type="pmid">26694970</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>X</given-names></name> <name><surname>Sharma</surname> <given-names>N</given-names></name> <name><surname>Kapadia</surname> <given-names>F</given-names></name> <name><surname>Zhou</surname> <given-names>G</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <name><surname>Hong</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Kruppel-like factor 4 regulates macrophage polarization</article-title>. <source>J Clin Invest.</source> (<year>2011</year>) <volume>121</volume>:<fpage>2736</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1172/JCI45444</pub-id><pub-id pub-id-type="pmid">21670502</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>SCC</given-names></name> <name><surname>Everts</surname> <given-names>B</given-names></name> <name><surname>Ivanova</surname> <given-names>Y</given-names></name> <name><surname>O&#x00027;Sullivan</surname> <given-names>D</given-names></name> <name><surname>Nascimento</surname> <given-names>M</given-names></name> <name><surname>Smith</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages</article-title>. <source>Nat Immunol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>846</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2956</pub-id><pub-id pub-id-type="pmid">25086775</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellini</surname> <given-names>A</given-names></name> <name><surname>Mattoli</surname> <given-names>S</given-names></name></person-group>. <article-title>The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses</article-title>. <source>Lab Invest.</source> (<year>2007</year>) <volume>87</volume>:<fpage>858</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.3700654</pub-id><pub-id pub-id-type="pmid">17607298</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Ren</surname> <given-names>P</given-names></name> <name><surname>Dawson</surname> <given-names>A</given-names></name> <name><surname>Vasquez</surname> <given-names>HG</given-names></name> <name><surname>Ageedi</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue</article-title>. <source>Circulation.</source> (<year>2020</year>) <volume>142</volume>:<fpage>1374</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.046528</pub-id><pub-id pub-id-type="pmid">33017217</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemaitre</surname> <given-names>V</given-names></name> <name><surname>Soloway</surname> <given-names>PD</given-names></name> <name><surname>D&#x00027;Armiento</surname> <given-names>J</given-names></name></person-group>. <article-title>Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1</article-title>. <source>Circulation.</source> (<year>2003</year>) <volume>107</volume>:<fpage>333</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000044915.37074.5C</pub-id><pub-id pub-id-type="pmid">12538437</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname> <given-names>SM</given-names></name> <name><surname>Seto</surname> <given-names>SW</given-names></name> <name><surname>Jose</surname> <given-names>RJ</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Morton</surname> <given-names>SK</given-names></name> <name><surname>Biros</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2017</year>) <volume>37</volume>:<fpage>553</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.308723</pub-id><pub-id pub-id-type="pmid">28062506</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van</surname> <given-names>Andel H</given-names></name> <name><surname>Kocemba</surname> <given-names>KA</given-names></name> <name><surname>Spaargaren</surname> <given-names>M</given-names></name> <name><surname>Pals</surname> <given-names>ST</given-names></name></person-group>. <article-title>Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options</article-title>. <source>Leukemia.</source> (<year>2019</year>) <volume>33</volume>:<fpage>1063</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/s41375-019-0404-1</pub-id><pub-id pub-id-type="pmid">30770859</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Medbury</surname> <given-names>HJ</given-names></name> <name><surname>Tarran</surname> <given-names>SL</given-names></name> <name><surname>Guiffre</surname> <given-names>AK</given-names></name> <name><surname>Williams</surname> <given-names>MM</given-names></name> <name><surname>Lam</surname> <given-names>TH</given-names></name> <name><surname>Vicaretti</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Monocytes contribute to the atherosclerotic cap by transformation into fibrocytes</article-title>. <source>Int Angiol.</source> (<year>2008</year>) <volume>27</volume>:<fpage>114</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/S1567-5688(08)70207-1</pub-id><pub-id pub-id-type="pmid">18427397</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikam</surname> <given-names>VS</given-names></name> <name><surname>Schermuly</surname> <given-names>RT</given-names></name> <name><surname>Dumitrascu</surname> <given-names>R</given-names></name> <name><surname>Weissmann</surname> <given-names>N</given-names></name> <name><surname>Kwapiszewska</surname> <given-names>G</given-names></name> <name><surname>Morrell</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension</article-title>. <source>Eur Respir J.</source> (<year>2010</year>) <volume>36</volume>:<fpage>1302</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00028009</pub-id><pub-id pub-id-type="pmid">20525716</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G</given-names></name> <name><surname>Lu</surname> <given-names>H</given-names></name> <name><surname>Chang</surname> <given-names>Z</given-names></name> <name><surname>Zhao</surname> <given-names>Y</given-names></name> <name><surname>Zhu</surname> <given-names>T</given-names></name> <name><surname>Chang</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta</article-title>. <source>Cardiovasc Res.</source> (<year>2021</year>) <volume>117</volume>:<fpage>1402</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvaa214</pub-id><pub-id pub-id-type="pmid">32678909</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Zhou</surname> <given-names>T</given-names></name> <name><surname>Stranz</surname> <given-names>A</given-names></name> <name><surname>DeRoo</surname> <given-names>E</given-names></name> <name><surname>Liu</surname> <given-names>B</given-names></name></person-group>. <article-title>Single-Cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm-brief report</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2021</year>) <volume>41</volume>:<fpage>1158</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.120.315607</pub-id><pub-id pub-id-type="pmid">33472403</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meher</surname> <given-names>AK</given-names></name> <name><surname>Johnston</surname> <given-names>WF</given-names></name> <name><surname>Lu</surname> <given-names>G</given-names></name> <name><surname>Pope</surname> <given-names>NH</given-names></name> <name><surname>Bhamidipati</surname> <given-names>CM</given-names></name> <name><surname>Harmon</surname> <given-names>DB</given-names></name> <etal/></person-group>. <article-title>B2 cells suppress experimental abdominal aortic aneurysms</article-title>. <source>Am J Pathol.</source> (<year>2014</year>) <volume>184</volume>:<fpage>3130</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2014.07.006</pub-id><pub-id pub-id-type="pmid">25194661</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaheen</surname> <given-names>B</given-names></name> <name><surname>Downs</surname> <given-names>EA</given-names></name> <name><surname>Serbulea</surname> <given-names>V</given-names></name> <name><surname>Almenara</surname> <given-names>CC</given-names></name> <name><surname>Spinosa</surname> <given-names>M</given-names></name> <name><surname>Su</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>B-cell depletion promotes aortic infiltration of immunosuppressive cells and is protective of experimental aortic aneurysm</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2016</year>) <volume>36</volume>:<fpage>2191</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307559</pub-id><pub-id pub-id-type="pmid">27634836</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van</surname> <given-names>Puijvelde GHM</given-names></name> <name><surname>Foks</surname> <given-names>AC</given-names></name> <name><surname>van</surname> <given-names>Bochove RE</given-names></name> <name><surname>Bot</surname> <given-names>I</given-names></name> <name><surname>Habets</surname> <given-names>KLL</given-names></name> <name><surname>de</surname> <given-names>Jager SC</given-names></name> <etal/></person-group>. <article-title>CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice</article-title>. <source>PLoS ONE.</source> (<year>2018</year>) <volume>13</volume>:<fpage>e0190962</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0190962</pub-id><pub-id pub-id-type="pmid">29346401</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takei</surname> <given-names>Y</given-names></name> <name><surname>Tanaka</surname> <given-names>T</given-names></name> <name><surname>Kent</surname> <given-names>KC</given-names></name> <name><surname>Yamanouchi</surname> <given-names>D</given-names></name></person-group>. <article-title>Osteoclastogenic differentiation of macrophages in the development of abdominal aortic aneurysms</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2016</year>) <volume>36</volume>:<fpage>1962</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.116.307715</pub-id><pub-id pub-id-type="pmid">27386936</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Byon</surname> <given-names>CH</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Yuan</surname> <given-names>K</given-names></name> <name><surname>Mao</surname> <given-names>X</given-names></name> <name><surname>Heath</surname> <given-names>JM</given-names></name> <etal/></person-group>. <article-title>Runx2-upregulated receptor activator of nuclear factor kappaB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2011</year>) <volume>31</volume>:<fpage>1387</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.110.222547</pub-id><pub-id pub-id-type="pmid">21454810</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cochain</surname> <given-names>C</given-names></name> <name><surname>Vafadarnejad</surname> <given-names>E</given-names></name> <name><surname>Arampatzi</surname> <given-names>P</given-names></name> <name><surname>Pelisek</surname> <given-names>J</given-names></name> <name><surname>Winkels</surname> <given-names>H</given-names></name> <name><surname>Ley</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Single-cell rna-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis</article-title>. <source>Circ Res.</source> (<year>2018</year>) <volume>122</volume>:<fpage>1661</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.312509</pub-id><pub-id pub-id-type="pmid">29545365</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pyo</surname> <given-names>R</given-names></name> <name><surname>Lee</surname> <given-names>JK</given-names></name> <name><surname>Shipley</surname> <given-names>JM</given-names></name> <name><surname>Curci</surname> <given-names>JA</given-names></name> <name><surname>Mao</surname> <given-names>DL</given-names></name> <name><surname>Ziporin</surname> <given-names>SJ</given-names></name> <etal/></person-group>. <article-title>Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms</article-title>. <source>J Clin Invest.</source> (<year>2000</year>) <volume>105</volume>:<fpage>1641</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1172/JCI8931</pub-id><pub-id pub-id-type="pmid">10841523</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>YW</given-names></name> <name><surname>Cao</surname> <given-names>X</given-names></name> <name><surname>Guo</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Pan</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice</article-title>. <source>Cardiovasc Res.</source> (<year>2012</year>) <volume>96</volume>:<fpage>401</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvs263</pub-id><pub-id pub-id-type="pmid">22871592</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname> <given-names>RW</given-names></name> <name><surname>Holmes</surname> <given-names>DR</given-names></name> <name><surname>Mertens</surname> <given-names>RA</given-names></name> <name><surname>Liao</surname> <given-names>S</given-names></name> <name><surname>Botney</surname> <given-names>MD</given-names></name> <name><surname>Mecham</surname> <given-names>RP</given-names></name> <etal/></person-group>. <article-title>Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages</article-title>. <source>J Clin Invest.</source> (<year>1995</year>) <volume>96</volume>:<fpage>318</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1172/JCI118037</pub-id><pub-id pub-id-type="pmid">7615801</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curci</surname> <given-names>JA</given-names></name> <name><surname>Liao</surname> <given-names>S</given-names></name> <name><surname>Huffman</surname> <given-names>MD</given-names></name> <name><surname>Shapiro</surname> <given-names>SD</given-names></name> <name><surname>Thompson</surname> <given-names>RW</given-names></name></person-group>. <article-title>Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms</article-title>. <source>J Clin Invest.</source> (<year>1998</year>) <volume>102</volume>:<fpage>1900</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1172/JCI2182</pub-id><pub-id pub-id-type="pmid">9835614</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hillebrands</surname> <given-names>JL</given-names></name> <name><surname>Onuta</surname> <given-names>G</given-names></name> <name><surname>Rozing</surname> <given-names>J</given-names></name></person-group>. <article-title>Role of progenitor cells in transplant arteriosclerosis</article-title>. <source>Trends Cardiovasc Med.</source> (<year>2005</year>) <volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcm.2004.10.002</pub-id><pub-id pub-id-type="pmid">15795157</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Just</surname> <given-names>SA</given-names></name> <name><surname>Lindegaard</surname> <given-names>H</given-names></name> <name><surname>Hejbol</surname> <given-names>EK</given-names></name> <name><surname>Davidsen</surname> <given-names>JR</given-names></name> <name><surname>Bjerring</surname> <given-names>N</given-names></name> <name><surname>Hansen</surname> <given-names>SWK</given-names></name> <etal/></person-group>. <article-title>Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis</article-title>. <source>Respir Res.</source> (<year>2017</year>) <volume>18</volume>:<fpage>141</fpage>. <pub-id pub-id-type="doi">10.1186/s12931-017-0623-9</pub-id><pub-id pub-id-type="pmid">28720095</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enzerink</surname> <given-names>A</given-names></name> <name><surname>Vaheri</surname> <given-names>A</given-names></name></person-group>. <article-title>Fibroblast activation in vascular inflammation</article-title>. <source>J Thromb Haemost.</source> (<year>2011</year>) <volume>9</volume>:<fpage>619</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/j.1538-7836.2011.04209.x</pub-id><pub-id pub-id-type="pmid">21255248</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Luo</surname> <given-names>H</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Huang</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Ma</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice</article-title>. <source>Circ Res.</source> (<year>2012</year>) <volume>111</volume>:<fpage>1261</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.270520</pub-id><pub-id pub-id-type="pmid">22912384</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McAnulty</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Fibroblasts and myofibroblasts: their source, function and role in disease</article-title>. <source>Int J Biochem Cell Biol.</source> (<year>2007</year>) <volume>39</volume>:<fpage>666</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2006.11.005</pub-id><pub-id pub-id-type="pmid">17196874</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y</given-names></name> <name><surname>O&#x00027;Brien</surname> <given-names>JE</given-names> <suffix>Jr</suffix></name> <name><surname>Fard</surname> <given-names>A</given-names></name> <name><surname>Zalewski</surname> <given-names>A</given-names></name></person-group>. Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair. <source>Arterioscler Thromb Vasc Biol.</source> (<year>1996</year>) <volume>16</volume>:<fpage>1298</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1161/01.ATV.16.10.1298</pub-id><pub-id pub-id-type="pmid">8857928</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname> <given-names>S</given-names></name> <name><surname>Fu</surname> <given-names>AA</given-names></name> <name><surname>Misra</surname> <given-names>KD</given-names></name> <name><surname>Shergill</surname> <given-names>UM</given-names></name> <name><surname>Leof</surname> <given-names>EB</given-names></name> <name><surname>Mukhopadhyay</surname> <given-names>D</given-names></name></person-group>. <article-title>Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access</article-title>. <source>J Vasc Interv Radiol.</source> (<year>2010</year>) <volume>21</volume>:<fpage>896</fpage>&#x02013;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvir.2010.02.030</pub-id><pub-id pub-id-type="pmid">20434368</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>SJ</given-names></name> <name><surname>Boyd</surname> <given-names>R</given-names></name> <name><surname>Zhu</surname> <given-names>M</given-names></name> <name><surname>Chapman</surname> <given-names>A</given-names></name> <name><surname>Pimentel</surname> <given-names>DR</given-names></name> <name><surname>Wang</surname> <given-names>HD</given-names></name></person-group>. <article-title>NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts</article-title>. <source>Cardiovasc Res.</source> (<year>2007</year>) <volume>75</volume>:<fpage>702</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2007.02.015</pub-id><pub-id pub-id-type="pmid">17391658</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>B</given-names></name> <name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Fu</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Cai</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>CYLD deubiquitinates nicotinamide adenine dinucleotide phosphate oxidase 4 contributing to adventitial remodeling</article-title>. <source>Arterioscler Thromb Vasc Biol.</source> (<year>2017</year>) <volume>37</volume>:<fpage>1698</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1161/ATVBAHA.117.309859</pub-id><pub-id pub-id-type="pmid">28751569</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akhmetshina</surname> <given-names>A</given-names></name> <name><surname>Palumbo</surname> <given-names>K</given-names></name> <name><surname>Dees</surname> <given-names>C</given-names></name> <name><surname>Bergmann</surname> <given-names>C</given-names></name> <name><surname>Venalis</surname> <given-names>P</given-names></name> <name><surname>Zerr</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis</article-title>. <source>Nat Commun.</source> (<year>2012</year>) <volume>3</volume>:<fpage>735</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms1734</pub-id><pub-id pub-id-type="pmid">22415826</pub-id></citation></ref>
</ref-list> 
</back>
</article> 